Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Zonisamide Solution, 1.0 mg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco Z0051ML
Description
Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic-clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran™.Specifications
67-56-1, 68291-97-4 | |
MFCD00865316 | |
1.0 mg/mL in methanol | |
Ampule | |
9.7°C (49.5°F) - closed cup |
C8H8N2O3S | |
UN 1230 - class 3 - PG 2 - Methanol, solution | |
212.23 | |
1 mL |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?
Provide Content Correction